'Most Controversial Issue' in Early Breast Cancer Treatment

In an online poll over use of chemotherapy for premenopausal patients with early breast cancer, votes were split without consensus; debate on this issue continues.

Related Keywords

Germany , Texas , United States , Dana Farber Cancer Institute , Massachusetts , Rhode Island , Boston , Italy , Austria , New Haven , Connecticut , Vienna , Wien , Dallas , Reggio Emilia , Emilia Romagna , Susang Komen , Haroldj Burstein , Eric Winer , Matteo Lambertini , Stephaniel Graff , Michael Gnant , Kim Sabelko , Paolo Tarantino , Twitter , Yale Cancer Center , Journal Of The National Cancer Institute , Centre Of Hematology , University Of Modena , Oncotype Dx Genomic Health , Lifespan Cancer Institute , University Of Vienna , San Antonio Breast Cancer Symposium , Medscape Medical , Genomic Health , Medical University , Sibylle Loibl , National Cancer Institute , Angela Toss , Medscape Medical News , Policlinico San Martino , Medscapemedical News , Breast Cancer , Alignant Breast Neoplasm , Chemotherapy , Cancer , Alignant Neoplasia , Arcinoma , Metastasis , Adjuvant Chemotherapy , Endocrine Therapy , Hormone Therapy , Her2 Negative Breast Cancer , Her2 Breast Cancer , Tamoxifen , Elective Estrogen Receptor Modulator Serm , Amenorrhea , Clinical Research , Clinical Trials , Linical Studies , Healthcare And Medical Technology , Ealth And Medical Tech , Health And ,